4.6 Article

Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation

期刊

JOURNAL OF OVARIAN RESEARCH
卷 14, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13048-021-00815-y

关键词

Epithelial ovarian cancer (EOC); Adipocytes; Sphingosine kinase 1 (SphK1); Sphingosine 1-phosphate receptor (S1PR); Proliferation

资金

  1. National Natural Science Foundation of China (NSFC) [81974401, 81974454]
  2. Science and Technology Commission of Shanghai municipality [18ZR1423100]
  3. Shanghai Municipal Commission of Health and Family Planning [2017YQ035]

向作者/读者索取更多资源

This study highlights the critical role of SphK1 in adipocyte-induced EOC cell proliferation, involving ERK phosphorylation and the S1PR1 and S1PR3 signaling pathways. The findings suggest a new potential target for EOC therapy.
Background Adipocytes, active facilitators of epithelial ovarian cancer (EOC) growth, have been implicated in the link between obesity and EOC. However, the current understanding of the mechanisms underlying adipocyte-induced EOC cell proliferation remains incomplete. Results We provide the first evidence showing that sphingosine kinase (SphK) 1 is critical for adipocyte-induced EOC cell proliferation. Adipocytes are capable of activating SphK1, which then leads to extracellular signal-regulated kinase (ERK) phosphorylation. Moreover, adipocyte-induced SphK1 activation is ERK dependent. Furthermore, sphingosine 1-phosphate receptor (S1PR) 1 and S1PR3, key components of the SphK1 signalling pathway, participate in adipocyte-mediated growth-promoting action in EOC cells. Conclusions Our study reveals a previously unrecognized role of SphK1 in adipocyte-induced growth-promoting action in EOC, suggesting a new target for EOC therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据